LGALS3 and telangiectasis: Since higher concentrations of Gal-3 were found in patients with lcSSc, and gastrointestinal manifestations and telangiectasias were more frequent in this clinical form of SSc (Table 1), the association of these clinical manifestations with the lcSSc clinical variant was evaluated.